Premature battery depletion due to compromised low‐voltage capacitor in a family of defibrillators.

Background: Boston Scientific (Marlborough, MA, USA) implantable cardioverter‐defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT‐Ds) manufactured between 2008 and 2014 are potentially subject to premature battery depletion through a low‐voltage capacitor malfunction occu...

Descripción completa

Detalles Bibliográficos
Publicado en:Pacing & Clinical Electrophysiology Vol. 42; no. 7; pp. 965 - 970
Autores principales: Montgomery, Jay A., Sensing, Janice Y., Saunders, Sandra D., Clair, Walter K., Abraham, Robert L., Kanagasundram, Arvindh N., Ellis, Christopher R., Crossley, George H., Shoemaker, Moore Benjamin, Saavedra, Pablo
Formato: pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell Jul2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137374780&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 137374780
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01478389
        4F8
      jtl: Pacing & Clinical Electrophysiology
      issn: 01478389
      maglogo: Y
    pubinfo:
      dt: Jul2019
      vid: 42
      iid: 7
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        137374780
        137374780
        137374780
        10.1111/pace.13713
        137374780
      ppf: 965
      ppct: 5
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Premature battery depletion due to compromised low‐voltage capacitor in a family of defibrillators.
      aug:
        au:
          Montgomery, Jay A.
          Sensing, Janice Y.
          Saunders, Sandra D.
          Clair, Walter K.
          Abraham, Robert L.
          Kanagasundram, Arvindh N.
          Ellis, Christopher R.
          Crossley, George H.
          Shoemaker, Moore Benjamin
          Saavedra, Pablo
        affil: Cardiovascular Division, Vanderbilt University Medical Center, Nashville Tennessee
      sug:
        subj:
          Defibrillators, Implantable Adverse Effects
          Cardiac Resynchronization Therapy Adverse Effects
          Prosthesis Failure Risk Factors
          Electric Impedance
          Power Sources
          Human
          Retrospective Design
          Time Factors
      ab: Background: Boston Scientific (Marlborough, MA, USA) implantable cardioverter‐defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT‐Ds) manufactured between 2008 and 2014 are potentially subject to premature battery depletion through a low‐voltage capacitor malfunction occurring as a result of hydrogen buildup within the device. Although some of these devices are currently under advisory, other devices manufactured during this timeframe carry a lower risk of the same malfunction. These same devices are known to have superior longevity in general, and the overall mean lifespan of the devices remains long. Methods: All patients implanted or followed at our two centers who experienced premature battery depletion and had a Boston Scientific ICD or CRT‐D potentially at risk for low‐voltage capacitor malfunction were studied retrospectively. Results: Nineteen out of 838 patients (2.3%) with devices potentially at risk have had premature battery depletion: 5.7% of those under advisory and 1.1% of those not under advisory. None of our patients had compromised therapy, and all had >27 days of projected battery longevity remaining. Conclusions: Undetected premature battery depletion in this population of ICDs has the potential to expose a patient to an interval of time where the device is unable to provide therapy. However, with enrollment in remote monitoring, regular follow‐up, and attention to audible alerts, the risk of therapy loss due to low‐voltage state can be effectively mitigated. For these reasons, prophylactic generator replacement is not recommended.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N